{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-242806","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.447429+00:00","generated_at":"2026-05-30T10:53:09.289019+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ResMed Q1 FY2025 revenue $1.22B (+11% YoY); EPS $2.11; non-GAAP EPS $2.20; dividend $0.53","bullets":["Revenue $1,224.5M, up 11% YoY (11% constant currency), driven by sleep device and mask demand.","GAAP diluted EPS $2.11; non-GAAP diluted EPS $2.20, up 34% YoY; operating profit up 34%.","Gross margin improved to 58.6% (non-GAAP 59.2%), up 420 bps YoY on manufacturing efficiencies.","Operating cash flow $326M; paid $78M dividends and repurchased $50M shares.","Board declared quarterly dividend of $0.53 per share, record date Nov 7, payable Dec 12."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-242806","json":"https://secwatch.observer/filing/0001193125-24-242806.json","markdown":"https://secwatch.observer/filing/0001193125-24-242806.md","text":"https://secwatch.observer/filing/0001193125-24-242806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/0001193125-24-242806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312524242806/d859390d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:53:09.289019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}